Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer's disease
作者： B. Tasso , M. Catto , O. Nicolotti , F. Novelli , M. Tonelli
DOI: 10.1016/J.EJMECH.2011.02.071
关键词:
摘要: … On the pattern of the potent and selective butyrylcholinesterase (BChE) inhibitors ethopropazine and Astra1397, sets of quinolizidinyl derivatives of bi- and tricyclic (hetero)aromatic …
core.ac.uk
elsevier.com
sci-hub.se 参考文章(74)
David Nachmansohn, Helen Schneemann, ON THE EFFECT OF DRUGS ON CHOLINESTERASE Journal of Biological Chemistry. ,vol. 159, pp. 239- 240 ,(1945) , 10.1016/S0021-9258(19)51322-9
Ezio Giacobini, Selective inhibitors of butyrylcholinesterase: A valid alternative for therapy of Alzheimer's disease? Drugs & Aging. ,vol. 18, pp. 891- 898 ,(2001) , 10.2165/00002512-200118120-00001
E. V. Rozengart, Bisalkaloid derivatives of dicarboxylic acids on the basis of lupinine, anabasine, and cytisine as reversible cholinesterase inhibitors. Doklady Biochemistry and Biophysics. ,vol. 388, pp. 39- 42 ,(2003) , 10.1023/A:1022560630021
Albert Enz, Rene Amstutz, H. Boddeke, G. Gmelin, J. Malanowski, BRAIN SELECTIVE-INHIBITION OF ACETYLCHOLINESTERASE - A NOVEL-APPROACH TO THERAPY FOR ALZHEIMERS-DISEASE Progress in Brain Research. ,vol. 98, pp. 431- 438 ,(1993) , 10.1016/S0079-6123(08)62429-2
Federica Novelli, Anna Sparatore, Bruno Tasso, Fabio Sparatore, Quinolizidinyl derivatives of 5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one as ligands for muscarinic receptors. Bioorganic & Medicinal Chemistry Letters. ,vol. 9, pp. 3031- 3034 ,(1999) , 10.1016/S0960-894X(99)00528-4
Qian-sheng Yu, Harold W. Holloway, Tadanobu Utsuki, Arnold Brossi, Nigel H. Greig, Synthesis of novel phenserine-based-selective inhibitors of butyrylcholinesterase for Alzheimer's disease. Journal of Medicinal Chemistry. ,vol. 42, pp. 1855- 1861 ,(1999) , 10.1021/JM980459S
Paul W. Elsinghorst, Camino M. González Tanarro, Michael Gütschow, Novel heterobivalent tacrine derivatives as cholinesterase inhibitors with notable selectivity toward butyrylcholinesterase. Journal of Medicinal Chemistry. ,vol. 49, pp. 7540- 7544 ,(2006) , 10.1021/JM060742O
George L. Ellman, K.Diane Courtney, Valentino Andres, Robert M. Featherstone, A new and rapid colorimetric determination of acetylcholinesterase activity Biochemical Pharmacology. ,vol. 7, pp. 88- 95 ,(1961) , 10.1016/0006-2952(61)90145-9
C.J. Van der Schyf, W.J. Geldenhuys, M.B.H. Youdim, Multifunctional neuroprotective drugs for the treatment of cognitive and movement impairment disorders, including Alzheimer's and Parkinson's diseases Drugs of The Future. ,vol. 31, pp. 447- 460 ,(2006) , 10.1358/DOF.2006.031.05.985904
Harish Kavirajan, Memantine: a comprehensive review of safety and efficacy Expert Opinion on Drug Safety. ,vol. 8, pp. 89- 109 ,(2009) , 10.1517/14740330802528420